Detalles de la búsqueda
1.
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.
Br J Haematol
; 204(2): 548-554, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904342
2.
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.
Haematologica
; 108(9): 2444-2453, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815381
3.
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
Eur J Haematol
; 110(4): 386-395, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539351
4.
Chronic lymphocytic leukaemia Australasian consensus practice statement.
Intern Med J
; 53(9): 1678-1691, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743239
5.
Indium-labelled autologous platelet sequestration studies predict response to splenectomy in immune thrombocytopenia: an Australian experience.
Intern Med J
; 52(8): 1387-1393, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945204
6.
Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Intern Med J
; 51(12): 2119-2128, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34505342
7.
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.
Hematol Oncol
; 37(3): 253-260, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30983008
8.
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
EJHaem
; 5(2): 325-332, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633125
9.
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(5): 739-741, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857117
10.
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.
Sci Rep
; 9(1): 13544, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537857
11.
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.
Blood Adv
; 3(7): 1084-1091, 2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944100
12.
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.
Leuk Lymphoma
; 58(1): 89-95, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27454522
13.
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.
Blood Adv
; 1(13): 802-811, 2017 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296724
14.
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.
Blood Adv
; 1(1): 31-35, 2016 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296693
Resultados
1 -
14
de 14
1
Próxima >
>>